The Impact of COVID-19 Infection on Multiple Sclerosis Disease Course Across 12 Countries: a Propensity-Score-matched Cohort Study
David Levitz,Yi Chao Foong,Paul Sanfilippo,Tim Spelman,Louise Rath,Angie Roldan,Anoushka Lal,Mastura Monif,Vilija Jokubaitis,Serkan Ozakbas,Raed Alroughani,Cavit Boz,Murat Terzi,Tomas Kalincik,Yolanda Blanco,Matteo Foschi,Andrea Surcinelli,Katherine Buzzard,Olga Skibina,Guy Laureys,Liesbeth Van Hijfte,Cristina Ramo-Tello,Aysun Soysal,Jose Luis Sanchez-Menoyo,Mario Habek,Elisabetta Cartechini,Juan Ignacio Rojas,Rana Karabudak,Barbara Willekens,Talal Al-Harbi,Yara Fragoso,Tamara Castillo-Trivino,Danny Decoo,Maria Cecilia Aragon de Vecino,Eli Skromne,Carmen-Adella Sirbu,Chao Zhu,Daniel Merlo,Melissa Gresle,Helmut Butzkueven,Anneke Van Der Walt THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS（2024）
Key words
COVID-19,disease progression,multiple sclerosis,relapse
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper